Healthcare provider profile · identity verified

Ryan Asterita

Internal Medicine · BRADENTON, FL · NPI 1649680562

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	998	281
Levothyroxine Sodium	Levothyroxine Sodium	588	157
Losartan Potassium	Losartan Potassium	582	164
Amlodipine Besylate	Amlodipine Besylate	537	156
Rosuvastatin Calcium	Rosuvastatin Calcium	522	171
Lisinopril	Lisinopril	338	97
Omeprazole	Omeprazole	321	102
Ozempic	Semaglutide	306	43
Trazodone Hcl	Trazodone Hcl	302	89
Metformin Hcl	Metformin Hcl	260	73
Pantoprazole Sodium	Pantoprazole Sodium	256	82
Simvastatin	Simvastatin	237	69
Tamsulosin Hcl	Tamsulosin Hcl	218	66
Alprazolam	Alprazolam	211	77
Metoprolol Succinate	Metoprolol Succinate	203	60
Hydrochlorothiazide	Hydrochlorothiazide	202	59
Zolpidem Tartrate	Zolpidem Tartrate	195	65
Allopurinol	Allopurinol	183	53
Gabapentin	Gabapentin	180	68
Mounjaro	Tirzepatide	177	31
Sertraline Hcl	Sertraline Hcl	167	49
Montelukast Sodium	Montelukast Sodium	162	46
Valsartan	Valsartan	147	41
Escitalopram Oxalate	Escitalopram Oxalate	137	37
Ezetimibe	Ezetimibe	137	47
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	136	38
Pravastatin Sodium	Pravastatin Sodium	125	40
Albuterol Sulfate Hfa	Albuterol Sulfate	112	40
Duloxetine Hcl	Duloxetine Hcl	106	27
Celecoxib	Celecoxib	102	32
Furosemide	Furosemide	100	35
Fluticasone Propionate	Fluticasone Propionate	97	35
Citalopram Hbr	Citalopram Hydrobromide	93	24
Finasteride	Finasteride	91	30
Famotidine	Famotidine	89	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	87	49
Bupropion Xl	Bupropion Hcl	85	26
Atenolol	Atenolol	82	20
Meloxicam	Meloxicam	78	31
Synthroid	Levothyroxine Sodium	76	23
Methylprednisolone	Methylprednisolone	74	64
Eliquis	Apixaban	70	17
Diazepam	Diazepam	69	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	20
Valacyclovir	Valacyclovir Hcl	67	30
Azithromycin	Azithromycin	64	60
Fluoxetine Hcl	Fluoxetine Hcl	64	17
Metoprolol Tartrate	Metoprolol Tartrate	61	18
Tramadol Hcl	Tramadol Hcl	61	23
Clonazepam	Clonazepam	58	13
Ipratropium Bromide	Ipratropium Bromide	56	16
Lorazepam	Lorazepam	56	20
Irbesartan	Irbesartan	55	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	55	20
Ramipril	Ramipril	53	13
Temazepam	Temazepam	53	suppressed
Spironolactone	Spironolactone	52	17
Alfuzosin Hcl Er	Alfuzosin Hcl	50	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	42
Esomeprazole Magnesium	Esomeprazole Magnesium	50	16
Glipizide	Glipizide	49	15
Metformin Hcl Er	Metformin Hcl	49	16
Clopidogrel	Clopidogrel Bisulfate	48	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	15
Xarelto	Rivaroxaban	48	11
Benazepril Hcl	Benazepril Hcl	47	11
Carvedilol	Carvedilol	46	14
Paroxetine Hcl	Paroxetine Hcl	46	13
Sumatriptan Succinate	Sumatriptan Succinate	46	11
Potassium Chloride	Potassium Chloride	45	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	44	33
Olmesartan Medoxomil	Olmesartan Medoxomil	44	13
Estradiol	Estradiol	42	suppressed
Ibuprofen	Ibuprofen	42	12
Doxycycline Hyclate	Doxycycline Hyclate	40	33
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	36	suppressed
Prednisone	Prednisone	36	29
Pregabalin	Pregabalin	31	13
Acyclovir	Acyclovir	30	11
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Hydrocortisone	Hydrocortisone	30	11
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	18
Mirtazapine	Mirtazapine	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	26
Fenofibrate	Fenofibrate	27	suppressed
Dutasteride	Dutasteride	26	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	11
Buspirone Hcl	Buspirone Hcl	23	suppressed
Cefdinir	Cefdinir	23	20
Colchicine	Colchicine	23	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Eszopiclone	Eszopiclone	21	suppressed
Fluconazole	Fluconazole	21	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	16
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	15
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	12
Terazosin Hcl	Terazosin Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	14
Jardiance	Empagliflozin	16	suppressed
Mupirocin	Mupirocin	16	15
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Linzess	Linaclotide	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Topiramate	Topiramate	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Praluent Pen	Alirocumab	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Nystatin	Nystatin	12	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	12	suppressed
Primidone	Primidone	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Ubrelvy	Ubrogepant	12	suppressed
Baclofen	Baclofen	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Repatha Syringe	Evolocumab	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error